NRT Smoking Cessation Aids in Greece
Euromonitor International's NRT Smoking Cessation Aids in Greece market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 35 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN GREECE : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 5 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 6 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 8 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - GREECE
ALAPIS SA - OTC HEALTHCARE - GREECE
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Alapis SA: Key Facts
Summary 2 Alapis SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
ELPEN SA - OTC HEALTHCARE - GREECE
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Elpen SA: Key Facts
Summary 4 Elpen SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Elpen SA: Competitive Position 2008
KORRES NATURAL PRODUCTS SA - OTC HEALTHCARE - GREECE
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Korres Natural Products SA: Key Facts
Summary 7 Korres Natural Products SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 Korres Natural Products SA: Competitive Position 2008
LAVIPHARM SA, LABORATOIRES - OTC HEALTHCARE - GREECE
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Laboratoires Lavipharm SA: Key Facts
Summary 10 Laboratoires Lavipharm SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 11 Laboratoires Lavipharm SA: Production capacity 2008
COMPETITIVE POSITIONING
Summary 12 Laboratoires Lavipharm SA: Competitive Position 2008
SARANTIS SA, GR - OTC HEALTHCARE - GREECE
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Sarantis SA, Gr: Key Facts
Summary 14 Sarantis SA, Gr: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Sarantis SA, Gr: Competitive Position 2008
OTC HEALTHCARE IN GREECE
EXECUTIVE SUMMARY
OTC healthcare sees steady retail value growth despite economic downturn
Demand for natural products increases
Trend of health and wellness benefits dynamic players
Healthfood stores find prosperous ground for expansion
Saturation in key categories expected to lead to slowdown in growth
KEY TRENDS AND DEVELOPMENTS
Increased migration and returning Greeks influence demand for products
The debate on reimbursement of “lifestyle medications”
Stressful lifestyles of consumers benefit OTC Healthcare
Alternative therapies and their impact
Manufacturers acknowledge the significance of communication
MARKET INDICATORS
Table 9 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Penetration of Private Label by Sector 2003-2008
Table 16 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 17 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 18 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 19 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Advertising
Packaging
Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Switches
DEFINITIONS
Summary 16 Research Sources